Create a free QxMD account to take advantage of the features offered by Read like saving your papers and creating collections.

Get Started

COMMENT

EDITORIAL

Aspirin for primary prevention of cardiovascular events in diabetes: still an open question

Antonio Nicolucci

JAMA 2008 November 12, 300 (18): 2180-1

No abstract text is available yet for this article.

Full Text Links

Find Full Text Links for this Article

Discussion

You are not logged in. Sign Up or Log In to join the discussion.

Related Papers

Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: a randomized controlled trial. Hisao Ogawa, Masafumi Nakayama, Takeshi Morimoto, Shiro Uemura, Masao Kanauchi, Naofumi Doi, Hideaki Jinnouchi, Seigo Sugiyama, Yoshihiko Saito JAMA 2008 November 12, 300 (18): 2134-41

Aspirin for primary prevention of cardiovascular events in diabetes. John A Colwell Diabetes Care 2003, 26 (12): 3349-50

[Should one prescribe aspirin for all diabetics?]. P Passa Diabetes & Metabolism 1997, 23 (6): 554-6

[Underutilization of acetylsalicylic acid of cardiovascular prevention in patients with diabetes mellitus]. Héctor Bueno Medicina Clínica 2004 January 31, 122 (3): 101-3

Aspirin for primary prevention of cardiovascular events in people with diabetes. Michael Pignone, Mark J Alberts, John A Colwell, Mary Cushman, Silvio E Inzucchi, Debabrata Mukherjee, Robert S Rosenson, Craig D Williams, Peter W Wilson, M Sue Kirkman Journal of the American College of Cardiology 2010 June 22, 55 (25): 2878-86

Does aspirin use reduce cardiovascular risk in diabetes? John A Colwell Nature Reviews. Endocrinology 2009, 5 (4): 188-90

Primary prevention of cardiovascular events with low-dose aspirin and vitamin E in type 2 diabetic patients: results of the Primary Prevention Project (PPP) trial. Michele Sacco, Fabio Pellegrini, Maria C Roncaglioni, Fausto Avanzini, Gianni Tognoni, Antonio Nicolucci Diabetes Care 2003, 26 (12): 3264-72

Long-term effects of cilostazol on the prevention of macrovascular disease in patients with type 2 diabetes mellitus. Sang Youl Rhee, Young Seol Kim, Suk Chon, Seungjoon Oh, Jeong-Taek Woo, Sung Woon Kim, Jin-Woo Kim Diabetes Research and Clinical Practice 2011, 91 (1): e11-4

Aspirin for primary prevention of cardiovascular events in patients with diabetes: A meta-analysis. Chunyu Zhang, Aijun Sun, Peng Zhang, Chaoneng Wu, Shuning Zhang, Mingqiang Fu, Keqiang Wang, Yunzeng Zou, Junbo Ge Diabetes Research and Clinical Practice 2010, 87 (2): 211-8

Aspirin therapy in diabetes mellitus. J A Colwell Diabetologia 1997, 40 (7): 867

Make the most of Read.
Download the mobile app.

Want full text access to this paper?

Use Read by QxMD to access full text via your institution or open access sources.

Read also provides personalized recommendations to keep you up to date in your field.

Existing User

New to Read

Aspirin for primary prevention of cardiovascular events in diabetes: still an open question

Discussion

Related Papers

Want full text access to this paper?

Save your favorite articles in one place with a free QxMD account.

Read

Search Tips